President Trump signs off on plan to fire FDA Commissioner Marty Makary

Dismissal Plan Signed

President Donald Trump has signed off on a plan to dismiss Food and Drug Administration (FDA) Commissioner Marty Makary. While the plan is not yet final and remains subject to change, reports indicate the president has approved the move.

This decision marks another high-profile departure within the health department led by Robert F. Kennedy Jr.. The move comes amid a period of instability at the agency, which has recently seen the departure of the biologics chief, Prasad, who stepped down last week.

Policy Clashes and Vaping Disputes

Reports indicate that the decision to remove Makary stems from a series of policy disagreements between the commissioner and the White House. A primary point of contention was Makary's hesitation to approve certain flavored vaping products.

Additionally, the administration expressed frustration over Makary's handling of drug policies and his oversight of the abortion pill. These controversies reportedly drew criticism from allies of the president and supporters of the Health Secretary.

Agency Turmoil and Leadership

Makary's tenure at the FDA has been described as tumultuous. The agency has been defined by a period of internal instability, including reported infighting among leadership and a series of staff departures.

Furthermore, the agency has faced challenges regarding regulatory decisions, specifically unexpected drug rejections during Makary's time as commissioner. These internal and external pressures contributed to the environment leading to the current plan for his ouster.